Efficacy and safety of different progestogens in women with first threatened miscarriage: A network meta‐analysis
International Journal of Gynecology & Obstetrics · 2025
DOI: 10.1002/ijgo.15987 ↗Kurz gefasst
Netzwerk-Metaanalyse in der Zeitschrift International Journal of Gynecology & Obstetrics, 2025. Verfasst von Hongqiong Zhao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Abortion, Threatened, Progestins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 52 Literaturangaben.
Abstract (Originalsprache)
Threatened miscarriage is defined as early vaginal bleeding before 12 weeks of gestational age and can occur in any pregnancy regardless of maternal age, race, comorbidities, lifestyle, or socioeconomic status, and about one‐quarter of threatened miscarriages proceed to complete miscarriage. To assess the relative effectiveness and safety of different progestogens in women with first threatened miscarriage, using a network meta‐analysis. A systematic search was conducted in PubMed, EMBASE, and Cochrane Library databases from inception to April 2023. Randomized controlled trials (RCTs) assessing the effectiveness or safety of placebo or different progestogens for the treatment of threatened miscarriage were eligible for inclusion, including dydrogesterone (oral), progesterone (oral, vaginal, rectal), and 17‐α‐hydroxyprogesterone (intramuscular). A Bayesian network meta‐analysis with Markov chain Monte‐Carlo simulation was performed in this study. A pairwise meta‐analysis was carried out by synthesizing studies that compared the same interventions using a fixed‐effects model. The primary outcome was the percentage of miscarriage (defined as delivery before 24 weeks of gestation) and preterm birth (defined as birth before 37 weeks of gestation), and the secondary outcomes were live birth rate, congenital abnormalities, neonatal outcomes (low birth weight
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Department of Gastroenterology, Chongqing Southeast Hospital, Chongqing, China.
- Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
ORCID-Profile: Zhu Yang
Zitieren
APA
Zhao, H., He, W., Xia, C., & Yang, Z. (2025). Efficacy and safety of different progestogens in women with first threatened miscarriage: A network meta‐analysis. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.15987
Vancouver
Zhao H, He W, Xia C, Yang Z. Efficacy and safety of different progestogens in women with first threatened miscarriage: A network meta‐analysis. International Journal of Gynecology & Obstetrics. 2025. doi:10.1002/ijgo.15987
BibTeX
@article{Zhao2025,
author = {Zhao, Hongqiong and He, Wei and Xia, Chunyu and Yang, Zhu},
title = {Efficacy and safety of different progestogens in women with first threatened miscarriage: A network meta‐analysis},
journal = {International Journal of Gynecology & Obstetrics},
year = {2025},
doi = {10.1002/ijgo.15987}
}
EUVIMED